Moleculin Biotech has begun dosing subjects in a Phase III trial of Annamycin with Cytarabine for treating acute myeloid ...
AML: Acute myeloid leukemia; CLL: C-type lectin-like molecule; CXCR: CXC chemokine receptor; N/A: Not applicable; NF: Nuclear factor. Acute myeloid leukemia (AML) remains incurable for the ...
News-Medical.Net on MSN15h
New drug target identified for treating acute myeloid leukemiaA team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...
The combination not only killed the leukemia cells, but also significantly reduced their infiltration into the bone marrow.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback